*このページは英語のみでご利用いただけます。
此页面仅提供英语版本。
This page is only available in English.
Established in 2003 in Singapore, Veredus Laboratories is a global biotechnology company that develops, manufactures and distributes products and services in the fields of molecular testing, clinical chemistry, point-of-care testing, and enzymes. It serves as the commercial center for the Asia region outside of Japan and China.
2003
Mamoru Takemura
42
83 Science Park Drive #04-02 The Curie Singapore 118258, Singapore
The diagnostics business is the core of the Group. It focuses on developing, manufacturing, and marketing in vitro diagnostics for hospitals laboratories, clinics and physician offices. Meeting the needs of customers through quality assays, our reagents and point-of-care tests are used to diagnose and monitor a wide range of conditions such as cardiovascular health, diabetes, and infectious diseases.
Our range of clinical chemistry reagents are used in measuring liver and renal function, lipid values, and more to help physicians diagnose and monitor patients. Through proprietary latex technology, we have also developed high-sensitivity reagents that can exclusively be used on certain instruments, as well as new reagents for biomarker measurement. This allows us to meet an even wider range of global diagnostic needs.
Our product lineup ranges from blood glucose control markers such as hemoglobin A1c and glycoalbumin, in addition to biomarkers for complication management and prediction involving insulin and other hormones, urinary L-FABP, urinary trace albumin and cystatin C. We contribute to diabetes medical examination by providing timely and accurate data to medical professionals and patients, during diagnosis and in understanding pathophysiology, follow-up and complication management.
Our compact instruments are effective in confined spaces and can quickly process a large number of samples. This contributes to a wide range of laboratory and diagnostics testing, including screening tests for blood coagulation abnormalities to biomarkers.
Our point-of-care testing (POCT) product line includes quantitative and qualitative tests based on immunochromatography technology developed over many years. These tests are especially crucial in diagnoses that require rapid response, such as infectious disease and immunology tests. In addition to using immunochromatography readers, we also provide molecular diagnostic products that support POCT.
We turn ideas into manufacturable products with end-to-end development support or step in at any stage to accelerate your progress—from design, refinement and prototyping to process development and optimization as well as regulatory documentation. All work is carried out in our ISO 13485 / ISO 9001 / ISO 14001 certified facility to ensure quality, compliance, and scalability.
We deliver reliable, scalable manufacturing with cleanroom capabilities, robust QA/QC, and full regulatory traceability. Our ISO 13485 / ISO 9001 / ISO 14001 certified facility ensures consistent, compliant production that meets the demands of medical and industrial applications.
